United States Court of Appeals
    for the Federal Circuit
                 ______________________

                     August 16, 2011

                      ERRATUM
                 ______________________

               Appeal No. 2010-1102,-1103

    IN RE BRIMONIDINE PATENT LITIGATION
           ----------------------------------------------
                    ALLERGAN, INC.,

                             v.

 EXELA PHARMSCI INC. and EXELA PHARMSCI
              PVT., LTD.,

                            and

         APOTEX INC. and APOTEX CORP.,


                 Decided: May 19, 2011
                  Precedential Opinion
                 ______________________

Please make the following change:

      Page 11, footnote 1, lines 9-10, the text should be
changed to read
      Dose Response Study” (“Derick”). The dissent
characterizes that article
